[india-drug] Antiretroviral medicines in the EDL

[Sunitha <sunitha9srinivas@yahoo.com>]

Antiretroviral medicines in the EDL
-----------------------------------


Dear all,

One of the members in the Drug and Therapeutic Committee in Karnataka
has brought up the aspect of inclusion of antiretroviral medicines in
the EDL in Karnataka.

His point of view is being enclosed:
?We have omitted it from the list of EDL in the 1st edition. Why should
it not be included under the tertiary category? It should be made
available within hours  to medical/paramedical personnel with h/o
accidental exposure. Is it not a good idea to store some of these in
the hospital for such purpose??

This has relevance to the 12th EDL released by WHO which has 325 active
substances, which include 12 ARVs and over 60 other essential medicines
for HIV-related care, including drugs against opportunistic infections.


Looking forward to the views of all the participants in this regard.

Best regards

Sunitha

C. Sunitha Srinivas
DIC, Karnataka State Pharmacy Council
Bangalore
Phone: 080-3383142, 3404000
Fax: 080-3202345
Email: sunitha9srinivas@yahoo.com


________________________________________________________________________
For live cricket scores download  Yahoo! Score Tracker
 at: http://in.sports.yahoo.com/cricket/tracker.html
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org